文献速递心脑血管急症重症综合管理与镇静镇痛

脑叶与深部原发性脑出血的血肿扩大差异

Hematoma Expansion Differences in Lobar and Deep Primary Intracerebral Hemorrhage.
PubMed 文献 · Neurocrit Care · 2019-01-01
一句话结论脑叶脑出血较深部脑出血血肿扩大(相对增长>33%)的 odds 更低(校正 OR 0.32,95%CI 0.11-0.93,p=0.04)。

该前瞻性单中心脑出血队列纳入2009至2016年收治的原发性脑出血患者,排除入院前抗凝药物使用、入院实验室检查提示凝血功能障碍或症状出现24小时后就诊者,分析有基线及随访CT(入院CT后24小时内)的59例脑叶与143例深部脑出血患者。以相对增长>33%为主要血肿扩大定义,校正基线血肿体积、血压和至CT时间后,脑叶脑出血血肿扩大 odds 低于深部脑出血(OR 0.32,95%CI 0.11-0.93,p=0.04)。以>6 mL或>33%或>6 mL定义时未见关联(校正 OR 1.44,95%CI 0.59-3.50,p=0.41;校正 OR 0.71,95%CI 0.29-1.70,p=0.44)。作者认为在基线血肿体积差异大的组间比较时,绝对增长阈值定义血肿扩大可能受限。

要点

  • 校正基线血肿体积、血压和至CT时间后,脑叶脑出血血肿扩大(>33%) odds 低于深部脑出血(OR 0.32,95%CI 0.11-0.93,p=0.04)。
  • 以>6 mL定义血肿扩大时,脑叶与深部脑出血无显著关联(校正 OR 1.44,95%CI 0.59-3.50,p=0.41)。
  • 以>33%或>6 mL联合定义时,脑叶与深部脑出血无显著关联(校正 OR 0.71,95%CI 0.29-1.70,p=0.44)。
  • 脑叶脑出血患者基线血肿体积显著更大、入院收缩压更低、至入院CT时间更长。
  • 作者认为,在基线血肿体积差异大的组间评估血肿扩大时,绝对增长阈值可能受限。

适用人群与场景

  • 2009至2016年收治的原发性脑出血患者,来自前瞻性单中心脑出血队列研究。
  • 排除入院前使用抗凝药物、入院实验室检查提示凝血功能障碍、或症状出现24小时后就诊的患者。
  • 分析对象为有基线及随访CT(入院CT后24小时内)的脑叶和深部脑出血患者。

诊断标准与关键阈值

  • 血肿扩大主要定义:相对增长>33%。
  • 其他常用血肿扩大定义:>6 mL,以及>33%或>6 mL。

研究设计与关键结果

  • 前瞻性单中心脑出血队列研究,纳入59例脑叶和143例深部脑出血患者。
  • 脑叶脑出血患者基线血肿体积显著更大、入院收缩压更低、至入院CT时间更长。
  • 多因素logistic回归校正基线脑出血体积、血压和至CT时间后,脑叶脑出血与血肿扩大(>33%) odds 降低相关(OR 0.32;95%CI 0.11-0.93;p=0.04)。
  • 次要分析未发现脑叶脑出血与血肿扩大(>6 mL)相关(校正 OR 1.44;95%CI 0.59-3.50;p=0.41)。
  • 次要分析未发现脑叶脑出血与血肿扩大(>33%或>6 mL)相关(校正 OR 0.71;95%CI 0.29-1.70;p=0.44)。

证据类型、等级与局限

  • 证据类型:前瞻性单中心队列研究。
  • 局限:原文报告需进一步研究以重复此发现并探究脑叶与深部脑出血血肿扩大差异的机制。

对床旁实践的改变

  • 作者认为,在评估基线血肿大小差异大的组间血肿扩大时,使用绝对增长阈值可能受限。
  • 作者认为,需进一步研究以重复此发现并探究脑叶与深部脑出血血肿扩大差异的机制。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Hematoma expansion (HE) after intracerebral hemorrhage (ICH) is associated with worse outcome. Lobar ICHs are known to have better outcomes compared to deep ICH; however, it is unclear whether there are HE differences between these locations. We sought to investigate the hypothesis that lobar ICH has less HE compared to deep ICH.

METHODS: Primary ICH patients admitted between 2009 and 2016 were included in a prospective single-center ICH cohort study. Patients with preceding anticoagulant use, coagulopathy on admission labs, or presenting after 24 h from symptom onset were excluded. Lobar and deep ICH patients with baseline and follow-up computed tomography (CT) (within 24 h of admission CT) were evaluated. HE was defined primarily as relative growth > 33% given expected baseline hematoma volume differences between locations. Other commonly utilized definitions of HE: > 6 mL, and > 33% or > 6 mL, were additionally assessed. Multivariable logistic regression was used to assess the association of ICH location with HE while adjusting for previously identified covariates of HE.

RESULTS: There were 59 lobar and 143 deep ICH patients analyzed. Lobar ICH patients had significantly larger baseline hematoma volumes, lower admission systolic blood pressure, and longer times to admission CT compared to deep ICH. Multivariable logistic regression revealed an association of lobar ICH with lower odds of HE (> 33%) [odds ratio (OR) 0.32; 95% confidence interval (CI) 0.11-0.93; p = 0.04] compared to deep ICH after adjusting for baseline ICH volume, blood pressure, and time to CT. Secondary analysis did not identify an association of lobar ICH with HE defined as > 6 mL (adjusted OR 1.44; 95% CI 0.59-3.50; p = 0.41) or > 33% or > 6 mL (adjusted OR 0.71; 95% CI 0.29-1.70; p = 0.44).

CONCLUSION: We identified less HE in lobar compared to deep ICH. The use of absolute growth thresholds in defining HE may be limited when assessing groups with largely different baseline hematoma sizes. Further study is required to replicate our findings and investigate mechanisms for HE differences between lobar and deep ICH locations.

来源:Neurocrit Care,查看原文。版权归原作者所有。

参考来源

  1. Roh D, Sun CH, Murthy S, et al. Hematoma Expansion Differences in Lobar and Deep Primary Intracerebral Hemorrhage. Neurocrit Care. 2019. PMID: 30756318. doi:10.1007/s12028-018-00668-2

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。